Lexapro Withdrawal & Alcohol: Stopping Safely and Mixing Wisely Learn about Lexapro withdrawal, how to safely stop, withdrawal symptoms, and the risks of drinking alcohol while on Lexapro. Find tips and timelines. Medically reviewed by John Smith, Jane Doe, Sarah Wilson Why Withdrawal Happens When discontinuing Lexapro, it’s common to experience withdrawal symptoms as your…

Lexapro vs. Zoloft, Wellbutrin & More: Choosing the Right Antidepressant for You Medically reviewed by John Smith, Jane Doe, Sarah Wilson Compare Lexapro, Zoloft, and Wellbutrin: Find out the differences in efficacy, side effects, and cost to choose the right antidepressant for your needs. SSRI vs NDRI at a Glance When considering antidepressant medications, it’s…

Lexapro Side Effects Guide: First Week Surprises, Long Term Changes & Women Specific Concerns Medically reviewed by John Smith, Jane Doe, Sarah Wilson Find out about common and uncommon Lexapro side effects, from the first week to long-term changes, plus women-specific concerns like weight gain and libido. Why Side Effects Happen When starting taking Lexapro,…

Going Generic: Escitalopram Savings, Brands, and What to Expect Medically reviewed by John Smith, Jane Doe, Sarah Wilson Learn how to save on Lexapro with generic escitalopram, compare costs, and find out what to expect with side effects, discounts, and generic Lexapro options. Brand vs Generic: Myth Busting When it comes to generic Lexapro (escitalopram),…

Escitalopram — Chemistry, Molecular Pharmacology & Pharmacogenomics Jane Doe, Michael Brown, Sarah Wilson Abstract Escitalopram, the S-enantiomer of racemic citalopram, is a widely used selective serotonin reuptake inhibitor (SSRI) approved for the treatment of major depressive disorder and generalized anxiety disorder. This review provides an in-depth look at escitalopram's molecular pharmacology, the significance of its…

Clinical Efficacy of Escitalopram Across Psychiatric and Somatic Disorders: 2019–2025 Umbrella Review Biao Wang, Keqing Li, Xiufeng Xu Abstract This umbrella review aggregates high-quality randomized controlled trials (RCTs) and meta-analyses published from 2019 to 2025, providing a definitive source for the clinical efficacy of escitalopram across psychiatric and somatic disorders. Escitalopram has demonstrated significant efficacy…

Therapeutic Evidence for Gabapentin in Humans & Animals Biao Wang, Keqing Li, Xiufeng Xu Abstract Gabapentin, a medication approved for the treatment of various conditions, including focal epilepsy, post-herpetic neuralgia (PHN), and neuropathic pain, has also found utility in psychiatric disorders, perioperative pain management, and veterinary applications. This umbrella systematic review aims to aggregate and…

Finding Your Dose: Lexapro 5 mg, 10 mg, 20 mg, 30 mg What Really Counts as ‘Low’ or ‘High’? Confused about Lexapro dosages? Learn about 5 mg, 10 mg, 20 mg, and 30 mg doses, what counts as low or high, and how to find your ideal dose for anxiety. Morning vs. Evening: Chrono Pharmacology…

Re-signalling the Blues: How Tadalafil Might Accelerate Antidepressant Response in Major Depressive Disorder Introduction: A New Angle on Antidepressant Acceleration Major depressive disorder (MDD) remains one of the most prevalent and disabling psychiatric conditions worldwide. Despite advances in pharmacotherapy, most first-line treatments, particularly selective serotonin reuptake inhibitors (SSRIs), require several weeks to take effect, and…

Antipsychotics Beyond Dopamine: The Muscarinic Turn Medically reviewed by Paul E. Bebbington, MA, MPhil, FRCPsych; Phern-Chern Tor, MBBS; and Pichet Udomratn, MD | Last updated: 12 June 2025 Introduction For more than half a century, antipsychotic treatment has rested on the pharmacological foundation of dopamine D2 antagonism: the idea that attenuating hyperdopaminergic signaling in striatal circuits would quell hallucinations,…